Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2165-2025Class II

Biofinity XR Toric Contact Lens

CooperVision, Inc. / initiated 2025-06-16 / Open, Classified / root cause: sterility

CooperVision, Inc. began a recall of Biofinity XR Toric Contact Lens on . FDA classified it as Class II and gives the reason as "Lens blisters may have an incomplete or leaking seal which may render them unsterile". As of , the recall status on record is Open, Classified, and MDM tags the root cause as sterility.

Recall record

Recall number
Z-2165-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
CooperVision, Inc.
Product
Biofinity XR Toric Contact Lens
Product code
LPM Lenses, Soft Contact, Extended Wear
Reason for recall
Lens blisters may have an incomplete or leaking seal which may render them unsterile.
Root cause tag
sterility
FDA root cause
Use error
Action
An URGENT MEDICAL DEVICE CORRECTION notice dated 6/27/25 was mailed to distributors, retailers, and physicians notifying them of this recall. The notification instructs consignees to inspect their inventory for affected devices and stop any further distribution/sale of affected devices. Practitioners are instructed to share the provided Consumer Communication Letter with any patients who received affected devices and to have patients return any units in their possession for replacement or credit. Consignees are to dispose of any affected product in their inventory or that is returned. Consignees are to complete and return the provided Correction Response Form via fax to 888-385-3217 or by email at [email protected]. Consignees with any complaints can contact the Customer Care Team at 855-526-6737; questions about this recall action can be directed to Customer Service at 800-341-2020.
Quantity in commerce
397 units
Distribution
Worldwide distribution - US Nationwide and the countries of Brazil, Canada, Honduras, and Mexico.
Product codes and lots
Carton Lot Numbers: RD0226792, RD0227007, RD0227022, RD0227030, RD0227032, RD0228123, RD0228336, RD0228465, RD0228570, RD0228595, RD0228598, RD0228603, RD0228606, RD0228607, RD0228775, RD0228778, RD0228788, RD0228795, RD0228798, RD0228799, RD0228802, RD0228809, RD0228814, RD0228825, RD0228835, RD0228840, RD0228842, RD0228847, RD0228853, RD0228854, RD0228855, RD0228866, RD0228875, RD0228876, RD0228940, RE0152731, RE0152735, RE0152737, RE0152740, RE0152743, RE0152744, RE0152755, RE0152760, RE0152775, RE0152799, RE0152838, RE0152871, RE0152873, RE0152877, RE0152883, RE0152889, RE0152891, RE0152913, RE0152915, RE0152917, RE0153804, RE0153819, RE0153924, RE0153974, RE0154076, RE0154085, RE0154095, RE0154100, RE0154103, RE0154105, RE0154107, RE0154113, RE0154114, RE0154117, RE0154137, RE0154139, RE0154143, RE0154253, RE0154256, RE0154259, RE0154264, RE0154271, RE0154329.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2165-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2165-2025Class IIOngoingVoluntary: Firm initiated
Z-2166-2025Class IIOngoingVoluntary: Firm initiated